Cancerologia de Queretaro S.C.
Queretaro, Mexico
Hospital in Santiago de Querétaro
Heraclio Cabrera , Col Ensueño, Calle Venustiano Carranza 62, Bosques del Acueducto, 76178 Santiago de Querétaro, Qro.
About Cancerologia de Queretaro S.C.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Cancerologia de Queretaro S.C.
During the past decade, Cancerologia de Queretaro S.C. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
1999-03-01
2012-12-01
Completed
5,351
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
2000-02-01
2019-11-01
Completed
2,130
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
2001-05-01
2011-02-01
Completed
1,598
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
2004-01-01
2009-04-01
Completed
134
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Cancerologia de Queretaro S.C.
According to Clinical.Site data, the most researched conditions in "Cancerologia de Queretaro S.C." are
"Follicular Lymphoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Cancerologia de Queretaro S.C." in a lesser frequency.
Clinical Trials Intervention Types at Cancerologia de Queretaro S.C.
Most popular intervention types in "Cancerologia de Queretaro S.C." are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Herceptin®" (1 trials), "MabThera®" (1 trials), "PF-05280014" (1 trials), "PF-05280586" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cancerologia de Queretaro S.C.
The vast majority of trials in "Cancerologia de Queretaro S.C." are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Cancerologia de Queretaro S.C.
Currently, there are NaN active trials in "Cancerologia de Queretaro S.C.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Cancerologia de Queretaro S.C.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Cancerologia de Queretaro S.C., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".